Bezafibrate
- TRADE NAMES: Bezalip (Roche); Bezamidin; Cedur; Nimus; Oralipin
- INDICATIONS: Hypercholesterolemia, hyperlipidemia, Type II diabetes
- CLASS: Antilipemic, Fibrate
- HALF-LIFE: 1–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Cholestyramine, Cyclosporine, HMG-CoA reductase inhibitors, MAO inhibitors, Warfarin
PREGNANCY CATEGORY: X
Please login to see the rest of this drug profile
SKIN.
HAIR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RENAL.
OTHER.
Page last updated 02/16/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric